Product References
Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Cell death and differentiation
Xu T,Verhagen MP,Teeuwssen M,Sun W,Joosten R,Sacchetti A,Ewing-Graham PC,Jansen MPHM,Boere IA,Bryce NS,Zeng J,Treutlein HR,Hook J,Hardeman EC,Gunning PW,Fodde R
Published figure using ESRP1 polyclonal antibody (Product # PA5-25833) in Western Blot
Fri Mar 01 00:00:00 UTC 2024
ESRP1 controls biogenesis and function of a large abundant multiexon circRNA.
Nucleic acids research
Liu D,Dredge BK,Bert AG,Pillman KA,Toubia J,Guo W,Dyakov BJA,Migault MM,Conn VM,Conn SJ,Gregory PA,Gingras AC,Patel D,Wu B,Goodall GJ
Published figure using ESRP1 polyclonal antibody (Product # PA5-25833) in Western Blot
Fri Feb 09 00:00:00 UTC 2024
The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing.
Cell reports
Mukhopadhyay D,Goel HL,Xiong C,Goel S,Kumar A,Li R,Zhu LJ,Clark JL,Brehm MA,Mercurio AM
Published figure using ESRP1 polyclonal antibody (Product # PA5-25833) in Western Blot
Tue Nov 28 00:00:00 UTC 2023
CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms.
Nucleic acids research
Batsché E,Yi J,Mauger O,Kornobis E,Hopkins B,Hanmer-Lloyd C,Muchardt C
PA5-25833 was used in Western Blot to explore the possibility of the impact of DNA methylation on alternative splicing that favors tumor progression.
Mon Jun 21 00:00:00 UTC 2021
Protocol for proteogenomic dissection of intronic splicing enhancer interactome for prediction of individualized cancer prognosis.
STAR protocols
Wang L,Wrobel JA,Xie L,Chen X
PA5-25833 was used in Western Blot to demonstrate a protocol for an alternative splicing activity-based proteogenomic approach for identification of candidate prognostic markers in cancer cell lines and human breast cancer specimens.
Fri Mar 19 00:00:00 UTC 2021
Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
Pigment cell & melanoma research
Marzese DM,Liu M,Huynh JL,Hirose H,Donovan NC,Huynh KT,Kiyohara E,Chong K,Cheng D,Tanaka R,Wang J,Morton DL,Barkhoudarian G,Kelly DF,Hoon DS
PA5-25833 was used in immunohistochemistry and western blot to examine CD44 variants during the progression of melanoma to melanoma brain metastasis.
Thu Jan 01 00:00:00 UTC 2015
Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
Pigment cell & melanoma research
Marzese DM,Liu M,Huynh JL,Hirose H,Donovan NC,Huynh KT,Kiyohara E,Chong K,Cheng D,Tanaka R,Wang J,Morton DL,Barkhoudarian G,Kelly DF,Hoon DS
PA5-25833 was used in immunohistochemistry and western blot to examine CD44 variants during the progression of melanoma to melanoma brain metastasis.
Thu Jan 01 00:00:00 UTC 2015
Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
Pigment cell & melanoma research
Marzese DM,Liu M,Huynh JL,Hirose H,Donovan NC,Huynh KT,Kiyohara E,Chong K,Cheng D,Tanaka R,Wang J,Morton DL,Barkhoudarian G,Kelly DF,Hoon DS
PA5-25833 was used in immunohistochemistry and western blot to examine CD44 variants during the progression of melanoma to melanoma brain metastasis.
Thu Jan 01 00:00:00 UTC 2015